Kobayashi Pharmaceutical Co Statistics
Want to see JP:4967 full AI Analyst Report?
Kobayashi Pharmaceutical Co (4967) Stock Statistics & Valuation Metrics
Total Valuation
Kobayashi Pharmaceutical Co has a market cap or net worth of JPY 519.36B. The enterprise value is JPY 462.48B.
- Market Cap
- JPY 519.36B
- Enterprise Value
- JPY 462.48B
Share Statistics
Kobayashi Pharmaceutical Co has 78,050,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 78,050,000
- Owned by Insiders
- ―
- Owned by Institutions
- 6.47%
Financial Efficiency
Kobayashi Pharmaceutical Co’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 6.77%.
- Return on Equity (ROE)
- 0.02
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- 6.77%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 44.42M
- Profits Per Employee
- 979.90K
- Employee Count
- 3,731
- Asset Turnover
- 0.60
- Inventory Turnover
- 3.56
Valuation Ratios
The current PE Ratio of Kobayashi Pharmaceutical Co is 112.92. Kobayashi Pharmaceutical Co’s PEG ratio is -1.87.
- PE Ratio
- 112.92
- PS Ratio
- 3.10
- PB Ratio
- 2.47
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -1.87
Income Statement
In the last 12 months, Kobayashi Pharmaceutical Co had revenue of 165.74B and earned 3.66B in profits. Earnings per share was 49.18.
- Revenue
- 165.74B
- Gross Profit
- 84.71B
- Operating Income
- 14.92B
- Pretax Income
- 3.74B
- Net Income
- 3.66B
- EBITDA
- 12.52B
- Earnings Per Share (EPS)
- 49.18
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Kobayashi Pharmaceutical Co pays an annual dividend of JPY 61.00, resulting in a dividend yield of 1.51%
- Dividend Per Share
- JPY 61.00
- Dividend Yield
- 1.51%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 0.89%
Stock Price Statistics
- Beta
- 0.34
- 52-Week Price Change
- 29.75%
- 50-Day Moving Average
- 6613.52
- 200-Day Moving Average
- 5878.66
- Relative Strength Index (RSI)
- 47.99
- Average Volume (3m)
- 265.26K
Important Dates
Kobayashi Pharmaceutical Co upcoming earnings date is Feb 16, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 10, 2026
- Next Earnings Date
- Feb 16, 2027
- Ex-Dividend Date
- Dec 29, 2026
Financial Position
Kobayashi Pharmaceutical Co as a current ratio of 2.47, with Debt / Equity ratio of 0.32%
- Current Ratio
- 2.47
- Quick Ratio
- 2.10
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -4.92
- Interest Coverage Ratio
- 532.96
Taxes
In the past 12 months, Kobayashi Pharmaceutical Co has paid 83.00M in taxes.
- Income Tax
- 83.00M
- Effective Tax Rate
- 0.02
Enterprise Valuation
Kobayashi Pharmaceutical Co EV to EBITDA ratio is 41.46, with an EV/FCF ratio of 0.00.
- EV to Sales
- 2.79
- EV to EBITDA
- 41.46
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Kobayashi Pharmaceutical Co has JPY 57.33B in cash and marketable securities with JPY 723.00M in debt, giving a net cash position of JPY 56.61B billion.
- Cash & Marketable Securities
- JPY 57.33B
- Total Debt
- JPY 723.00M
- Net Cash
- JPY 56.61B
- Net Cash Per Share
- JPY 725.25
- Tangible Book Value Per Share
- JPY 2,597.65
Margins
Gross margin is 49.66%, with operating margin of 6.10%, and net profit margin of 2.75%.
- Gross Margin
- 49.66%
- Operating Margin
- 6.10%
- Pretax Margin
- 2.66%
- Net Profit Margin
- 2.75%
- EBITDA Margin
- 6.72%
- EBIT Margin
- 0.98%
Analyst Forecast
The average price target for Kobayashi Pharmaceutical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 2.46%
- EPS Growth Forecast
- -60.25%
Scores
- Smart Score
- ―
- AI Score
- 61
